PGY2 Oncology Specialty Residency

The PGY2 Oncology Specialty Residency at City of Hope, a National Cancer Institute (NCI)-designated Comprehensive Cancer Center, is a structured one year program designed to provide the resident with a solid foundation of core experiences in hematology, oncology and stem cell transplant. The program provides broad-based rotational experiences to help develop and refine the resident's clinical skills in the pharmaceutical management of cancer patients. A resident completing the PGY2 Oncology Residency at City of Hope will be a highly qualified independent practitioner able to provide and be responsible for drug therapy outcomes for individualized patients as an integral member of the multidisciplinary healthcare team.

The goal for our PGY2 Specialty Oncology Resident is to:
  • Develop expertise, knowledge and skills in oncology therapeutics.
  • Be responsible for achieving optimal drug therapy outcomes as members of the multi-disciplinary healthcare team.
  • Skillfully educate other healthcare professionals and patients on drug-related topics.
  • Exercise leadership in improving the safety of the medication-use system.
  • Strengthen verbal and written communication skills by leading discussion, presenting lectures and writing manuscripts.
  • Demonstrate professional maturity by following a personal philosophy of practice, monitoring his/her own performance and exhibiting commitment to the profession.

While in the program, participants will:
  • Complete projects chosen with the program director’s input.
  • Attend educational meetings and conferences.
  • Gain experience in hospital pharmacy administration through a structured program provided by the residency director and director of pharmacy.
  • Be given the opportunity to obtain ACLS (advanced cardiac life support) certification.

For the pharmacy resident who seeks additional training in specialty areas, the following elective rotations are offered (rotation length varies depending on particular rotation and scheduling considerations):
  • Investigational Drug Service
  • Anticoagulation Clinic
  • Critical Care
  • Administration II
  • Other (Clinical Nutrition, Respiratory Therapy, etc.)

Research Project
The resident is required to design, develop and complete an original hematology or oncology-related research project. To expand understanding of and compliance with research requirements, the resident is required to design and submit a research proposal to IRB for approval. Additionally the resident is expected to present the findings at a national hematology/oncology meeting and produce a manuscript. The residency project will be selected based on the resident’s interest and developed in conjunction with the program director and project preceptors.

Other Resident Activities
The resident is required to participate in the following longitudinal activities:
  • Committee Involvement:
    • Pharmacy and Therapeutics Committee

    • Safe Medication Committee
  • Projects:
    • Research Project

    • Administrative Projects
  • Educational Lectures:
    • A one-hour ACPE-accredited CE presentation to the pharmacy staff

    • A one-hour lecture for Western University pharmacy students

    • Journal club presentations, patient case presentations and other rotation-based talks and in-services

    • Presentation at Pharmacy Professional Enrichment Series
  • Other:
    • Teaching/precepting pharmacy students and residents

    • Drug Utilization Evaluation

    • Medication Monographs and Formulary Review

    • Presentation of Residency Research Project at National Meetings

    • Community and Patient Events

    • Attending multi-disciplinary conferences

Resident Qualifications
  • The candidate should be comfortable and competent in clinical situations, motivated, independent and self-directed.
  • The candidate must be a graduate of an ACPE-accredited school of pharmacy and possess a Pharm.D. degree.
  • The candidate must have completed a first year PGY1 residency.
  • The candidate must be licensed as a pharmacist in the state of California by September 1 of the year in which he/she will start the PGY2 residency.

General Residency Info
Program Director
Sepideh Shayani, Pharm.D., BCOP

Pharmacy Director
Carl Kildoo, Pharm.D.

The residency program starts during the first week of July.